share_log

昭衍新药(06127)一季度归母净亏损2.72亿元

Zhaoyan Pharmaceutical (06127) lost 272 million yuan to mother in the first quarter

Zhitong Finance ·  Apr 29 07:12

According to the Zhitong Finance App, Zhaoyan Pharmaceutical (06127) released its report for the first quarter of 2024. Operating revenue was 325 million yuan (RMB, same below), down 12.07% year on year; net loss attributable to shareholders of listed companies was 272 million yuan, profit of 188 million yuan for the same period last year; basic loss per share was 0.36 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment